Stock listing

Hamburg:CHY ChemoMetec A/S Aktie

German listing (Hamburg) of ChemoMetec A/S · home listing Copenhagen:CHEMM

Follow ChemoMetec A/S into a list and get an email when it puts out news.

Home listing price · OMXCOP:CHEMM

682.00 DKK -12.50 (-1.8%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, OMXCOP:CHEMM

Past year -10.3% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
680.50 – 698.00 DKKNov 20, 2026
Volume
45,436 sharesNov 20, 2026
Market cap
11.70B DKKAt the close on Nov 20, 2026 · price × 17.16M shares outstanding
52-week range
235.20 – 788.00 DKKLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
36.92M DKKMedian day 49,120 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
ChemoMetec A/S logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Copenhagen:CHEMM · Home682.00 DKK-12.50 (-1.8%)45,436695.00698.00680.50694.50Close on Nov 20, 2026
Frankfurt:CHY€89.65 EUR-3.00 (-3.2%)—€91.50€92.30€89.65€92.65Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OMXCOP:CHEMM · DKK, adjusted for splits

DayCloseChange%OpenHighLowVolume
682.00-12.50-1.8%695.00698.00680.5045,436
694.50+6.50+0.9%690.00702.50688.0038,800
688.00-10.00-1.4%695.00695.50682.5038,692
698.00+9.50+1.4%688.50704.00687.5037,986
688.50+3.50+0.5%684.00699.50684.0046,039
685.00-23.50-3.3%710.50720.00681.0088,741
708.50-18.00-2.5%724.00728.00708.0046,305
726.50+20.50+2.9%724.50744.50722.0074,691
706.00+34.50+5.1%670.00713.50661.50118,650
671.50+26.50+4.1%660.00679.00640.0075,730
645.00-9.50-1.5%648.00661.50643.0066,853
654.50+35.00+5.6%613.00656.50596.50180,602
619.50+8.50+1.4%623.00639.00617.5048,102
611.00-10.00-1.6%623.00626.50609.5024,975
621.00+11.00+1.8%608.00622.50601.5038,128
610.00+2.00+0.3%614.00619.50603.0033,649
608.00-1.50-0.2%611.50615.00604.0027,720
609.50+17.00+2.9%591.00611.50587.5041,261
592.50-2.50-0.4%594.00594.00576.0027,684
595.00-1.50-0.3%596.50601.50587.0034,130
596.50+20.50+3.6%578.00596.50578.0051,626
576.00+9.00+1.6%569.50580.00568.0042,516
567.00-2.00-0.4%571.00578.50561.5037,309
569.00-7.00-1.2%576.00581.50569.0026,270
576.00-5.00-0.9%580.50583.50572.5033,750
581.00+12.00+2.1%569.50587.50569.0049,120
569.00-15.50-2.7%584.50587.00568.5056,684
584.50-2.00-0.3%587.50592.00578.5034,278
586.50+31.00+5.6%560.50589.00560.5060,052
555.50-12.00-2.1%568.00581.00555.5058,952
567.50-12.50-2.2%580.50587.00563.0071,114
580.00-5.00-0.9%593.00607.00580.0081,481
585.00+34.50+6.3%552.50606.00549.50173,972
550.50+31.50+6.1%520.00554.00508.0083,079
519.00-4.00-0.8%524.50525.50513.5028,137
523.00+3.50+0.7%521.50526.50518.0043,235
519.50-3.00-0.6%523.50525.50511.0065,731
522.50+7.50+1.5%518.00525.00517.0043,631
515.00-10.00-1.9%525.50529.00511.5035,844
525.00+8.50+1.6%514.00525.00511.0026,675
516.50+1.50+0.3%515.00525.00515.0028,368
515.00-10.00-1.9%525.50525.50513.0045,017
525.00+15.00+2.9%510.50533.00510.50106,089
510.00-11.50-2.2%522.00526.50504.0079,246
521.50+20.00+4.0%505.50521.50500.5058,916
501.50+9.10+1.8%493.80511.00493.4072,396
492.40+9.40+1.9%483.00492.40473.0094,837
483.00-9.80-2.0%492.80498.80476.0086,879
492.80-29.70-5.7%487.80515.00464.40325,515
522.50+7.50+1.5%517.00525.00513.0067,015
515.00-3.50-0.7%522.00528.00507.00123,997
518.50+5.50+1.1%513.00535.50511.00132,510
513.00+3.00+0.6%510.00519.50509.0039,506
510.00-6.50-1.3%523.00526.00509.0041,614
516.50+34.70+7.2%505.00532.00505.00137,240
481.80+6.80+1.4%472.00482.80465.2097,001
475.00-21.60-4.3%495.60495.60470.2070,115
496.60-7.40-1.5%501.00507.50495.0045,602
504.00+2.50+0.5%500.50508.50500.5044,344
501.50+9.50+1.9%490.40503.50490.0024,907
492.00-4.80-1.0%496.80500.00490.0024,262
496.80+9.80+2.0%489.00501.00489.0099,054
487.00-0.40-0.1%478.00490.80469.6063,076
487.40+12.20+2.6%478.00494.80476.2051,370
475.20-7.80-1.6%482.20492.00414.2082,848
Ticker
Hamburg:CHY
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
Hamburg
Currency
EUR

What changed lately

Latest news

All ChemoMetec A/S news

ChemoMetec A/S on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
10 in the last 12 months · 19 in all · newest Sep 10, 2026 · oldest 2025
Decks
1 deck · latest Feb 6, 2024

Where ChemoMetec A/S is listed

ListingExchangeCountryCurrency
Copenhagen:CHEMM · Home listingCopenhagenDenmarkDKK
gettex:CHYgettexGermanyEUR
LSIN:0DZ0LSINUnited KingdomDKK
Tradegate:CHYTradegateGermanyEUR
LS Exchange:A0MS80LS ExchangeGermanyEUR
Lang & Schwarz:A0MS80Lang & SchwarzGermanyEUR
Frankfurt:CHYFrankfurtGermanyEUR
Aquis:CHEMMCAquisUnited KingdomDKK
Stuttgart:CHYStuttgartGermanyEUR
OTC:CHHMFOTCUnited StatesUSD
Munich:CHYMunichGermanyEUR
Aquis:CHEMMCAquisUnited KingdomDKK
Dusseldorf:CHYDusseldorfGermanyEUR
Hamburg:CHY · This pageHamburgGermanyEUR
Turquoise:CHEMMCTurquoiseUnited KingdomDKK

Valuation

P/E 58.0× against a median of 76.0×: 3rd lowest of 5 Diagnostics & research services companies shown. Statements: Year to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
11.42B DKK
P/E
58.0×
EV/sales
22.3×
EV/EBITDA
40.6×
Price/book
16.1×
Gross margin
95.1%
Operating margin
49.1%
Net margin
39.5%
Debt to equity
0.0×
Beta
No index for this market yet

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
ChemoMetec A/S · OMXCOP:CHEMMUS$1.72BUS$1.68B58.0×22.3×40.6×16.1×39.5%0.0×n/a
OneSource Specialty Pharma Limited · NSE:ONESOURCEUS$1.99BUS$2.18Bn/a12.0×50.9×3.1×−0.1%0.3×n/a
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. Class A · SSE:603456US$1.98BUS$1.78B22.0×2.2×n/a1.5×11.3%0.0×n/a
Azenta, Inc. · NASDAQ:AZTAUS$1.96BUS$1.63Bn/a2.6×n/a1.4×−26.9%0.0×1.59
Syngene International Ltd. · NSE:SYNGENEUS$1.96BUS$1.96B97.5×5.2×20.0×3.7×5.3%0.1×n/a
Cohance Lifesciences Ltd · NSE:COHANCEUS$1.91BUS$1.88B167×8.1×55.1×4.5×5.0%0.1×n/a
Alamar Biosciences, Inc. · NASDAQ:ALMRUS$1.84BUS$1.66Bn/a14.5×n/a6.1×−48.2%0.1×1.70
Fortrea Holdings Inc. · NASDAQ:FTREUS$1.79BUS$2.62Bn/a1.0×28.7×3.4×−2.6%2.0×1.68
GemPharmatech Co., Ltd. Class A · SSE:688046US$1.65BUS$1.49B54.4×10.5×n/a4.7×21.5%0.0×n/a
PolyPeptide Group AG · SIX:PPGNUS$1.62BUS$1.70Bn/a4.0×34.1×4.2×−5.4%0.4×n/a
Personalis, Inc. · NASDAQ:PSNLUS$1.55BUS$1.39Bn/a17.3×n/a7.3×−147.7%0.2×2.03
Median of the othersUS$1.87BUS$1.74B76.0×6.7×34.1×4.0×−1.3%0.1×1.69

Forecasts

Analysts' consensus from EODHD, read Nov 11, 2026. Not 6ix's view and not investment advice.

Price target
780.00 DKK · Analysts' mean
EPS, year to Jun 2027
14.64 · 3 analysts
Revenue, year to Jun 2027
607M · 3 analysts

Team and board

Officers

OfficerRole
Martin Helbo BehrensCEO
Phillip Massie PriceCFO
Andrey GorinLaboratory Manager
Glenn WinnierChief Scientific Officer

Board

DirectorRole
Niels ThestrupChairman of the Board
Betina HagerupMember of the Board of Directors
Kristine FærchMember of the Board of Directors
Martin GlensbjergDeputy Chairman
Peter ReichMember of the Board of Directors

Events

Next results
Feb 2, 2027 (expected)
QuarterResultsShare move
Quarter to Mar 31, 2025May 7, 2025−5.4%
Q2 2025Feb 5, 2025+5.6%
Quarter to Sep 30, 2024Nov 7, 2024+29.8%
Q4 2024Sep 11, 2024 · After close+0.2%
Q3 2024May 8, 2024 · Before open−0.6%
Q2 2024Feb 5, 2024 · After close+24.0%
Q1 2024Nov 7, 2023 · After close+7.5%
Q4 2023Sep 13, 2023 · After close−4.4%
Q3 2023May 9, 2023+4.1%
Q2 2023Feb 9, 2023−22.1%
All 18 quarters
QuarterResultsShare move
Q1 2023Nov 8, 2022 · After close+0.4%
Q4 2022Sep 15, 2022 · Before open+0.2%
Q3 2022May 5, 2022 · Before open+0.8%
Q2 2022Feb 8, 2022 · After close+3.8%
Q1 2022Nov 4, 2021 · Before open+0.4%
Q4 2021Sep 15, 2021 · After close+3.0%
Q3 2021May 6, 2021−4.3%
Q2 2021Feb 5, 2021 · After close+3.0%

Open Events

Decks

DeckKindSlidesDate
H1 2023/24 Earnings PresentationEarnings14 slidesFeb 6, 2024

Open Decks

Financials

Annual, in DKK

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue511.1M495.6M407.4M444.4M428.4M281.1M214.1M175.5M112.7M90.3M
Cost of revenue25.1M30.1M40.3M49.0M44.1M27.8M20.2M16.9M13.2M10.1M
Gross profit486.0M465.5M367.6M395.4M384.3M253.3M193.9M158.6M99.5M80.2M
Research and development15.4M10.4M8.39M7.16M7.23M6.49M6.48M5.69M3.69M3.80M
Selling, general and administrative41.3M23.4M25.7M24.1M20.3M20.2M
Operating income251.0M236.5M169.0M228.5M201.5M116.0M77.5M54.1M24.3M10.4M
Depreciation and amortization30.3M21.5M17.2M20.4M20.0M19.6M15.1M10.8M5.79M5.45M
EBITDA281.3M258.0M186.2M248.9M221.6M135.6M92.6M64.9M30.1M15.9M
Interest expense392.0K17.4M1.28M1.09M1.52M918.0K1.19M716.0K887.0K1.07M
Income before tax258.2M225.0M176.6M230.4M203.2M112.7M75.9M53.7M23.3M8.65M
Income tax56.3M50.3M40.3M51.7M43.8M24.4M16.8M11.9M5.09M1.17M
Net income201.8M174.7M136.3M178.7M159.5M88.4M59.2M41.8M18.2M7.49M
Earnings per share, basic11,600.0010,040.007.8310.279.165.083.512.691.170.48
Earnings per share, diluted11,600.0010,040.007.83

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents290.2M341.8M296.1M316.6M209.0M150.1M96.9M98.2M9.78M12.4M
Short-term investments3.39M-93.8M-82.6M
Receivables99.2M79.6M69.1M59.7M65.9M62.6M44.3M36.0M19.6M14.7M
Inventory126.2M120.8M119.5M112.6M66.8M30.1M25.1M19.5M16.8M13.3M
Current assets524.8M554.6M489.8M492.7M352.9M244.4M168.3M154.8M46.8M41.0M
Property, plant and equipment126.6M115.6M92.0M82.7M74.8M42.5M43.4M38.1M28.9M26.4M
Goodwill7.36M7.35M0
Total assets860.9M839.5M676.7M658.0M501.3M344.9M263.1M238.2M114.0M97.6M
Accounts payable38.1M16.1M11.1M17.6M17.0M8.71M8.43M9.71M7.26M4.89M
Current liabilities128.2M143.7M98.5M119.2M137.4M72.0M47.7M55.0M17.9M21.1M
Long-term debt017.8M10.9M
Total debt4.59M6.40M4.16M7.16M6.79M2.36M2.29M18.8M20.1M22.1M
Total liabilities135.5M151.4M111.4M124.9M144.1M79.9M60.4M64.9M41.0M33.2M
Shareholders' equity725.4M688.1M565.3M533.0M357.2M265.0M202.8M173.3M73.0M64.4M
Shares outstanding17.4M17.4M17.4M17.4M17.4M17.4M16.9M15.6M15.5M15.7M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations210.4M207.4M129.0M154.1M176.9M107.9M72.0M58.3M25.4M9.76M
Capital spending-28.3M-29.9M-20.9M-40.8M-55.9M-24.6M-26.7M-27.1M-16.5M-10.6M
Free cash flow182.0M177.6M108.1M113.3M120.9M83.3M45.3M31.2M8.97M-833.0K
Cash from investing-99.8M-85.5M-43.5M-40.8M-56.0M-24.7M-26.6M-27.1M-16.5M-10.3M
Cash from financing-161.6M-75.0M-105.7M-2.92M-69.0M-26.0M-46.3M57.8M-7.93M-355.0K
Dividends paid-121.8M-69.6M-104.4M-69.6M-26.1M-348.1M-136.0M-136.0M-136.0M
Share buybacks-38.6M1.87M-9.57M
Change in cash-51.0M47.0M-20.2M107.5M58.9M53.2M-1.25M89.0M933.0K-1.70M

Open Financials

Cap table

Built by 6ix from ChemoMetec A/S’ releases

Common shares
17,162,529
Fully diluted
17,162,529

Fully diluted

LineShares
Common shares17,162,529

Share count over time

CountShares
Nov 22, 202617,162,529

Open Cap table

Shareholders

HolderSharesValueChangeAs of
Fidelity Contrafund530KUS$29.3MNo changeJun 30, 2026
Invesco International Small-Mid Company Fund457KUS$30.5MNo changeJul 31, 2026
Vanguard Total International Stock Index Fund244KUS$16.3MNo changeJul 31, 2026
Invesco Global Opportunities Fund188KUS$12.6M+7,464Jul 31, 2026
Vanguard Developed Markets Index Fund168KUS$9.34M+8,171Jun 30, 2026
iShares Core MSCI EAFE ETF121KUS$8.06M+1,404Jul 31, 2026
Fidelity Contrafund K6110KUS$6.09M−1,411Jun 30, 2026
Vanguard Ftse All-World Ex-Us Small-Cap Index Fund67,891US$4.53M+4,059Jul 31, 2026
Goldman Sachs International Small Cap Insights Fund63,316US$4.23M−13,341Jul 31, 2026
iShares MSCI EAFE Small-Cap ETF61,952US$4.13M−6,598Jul 31, 2026
Show 50 holders
HolderSharesValueChangeAs of
Vanguard European Stock Index Fund40,739US$2.72M+347Jul 31, 2026
Schwab International Small-Cap Equity ETF34,546US$2.02M−1,573May 31, 2026
International Opportunities Fund29,722US$1.74M+4,825May 31, 2026
iShares Core MSCI Total International Stock ETF27,556US$1.84M+320Jul 31, 2026
BlackRock International Select Equity Fund25,637US$1.42M−537Jun 30, 2026
Grandeur Peak Global Opportunities Fund19,291US$1.29M+6,227Jul 31, 2026
Large-Cap Growth Portfolio18,524US$1.03MNo changeJun 30, 2026
iShares Core MSCI International Developed Markets ETF18,265US$1.22MNo changeJul 31, 2026
Dimensional International Small Cap ETF18,222US$1.21M−1,411Jul 31, 2026
iShares MSCI Denmark ETF17,043US$992K+245May 31, 2026
International Core Equity 2 Portfolio16,720US$1.12MNewJul 31, 2026
Vanguard Total World Stock Index Fund15,833US$1.06M+3,387Jul 31, 2026
Old Westbury Small & Mid Cap Strategies Fund15,250US$1.02MNo changeJul 31, 2026
Avantis International Equity ETF14,717US$856KNo changeMay 31, 2026
State Street(R) SPDR(R) Portfolio Developed World ex-US ETF14,403US$798K−16Jun 30, 2026
The Continental Small Company Series12,429US$830K−32,187Jul 31, 2026
College Retirement Equities Fund - Total Global Stock Account12,314US$684KNo changeJun 30, 2026
State Street(R) SPDR(R) S&P(R) International Small Cap ETF11,290US$625K+120Jun 30, 2026
Fidelity Total International Index Fund10,486US$700K+1,002Jul 31, 2026
iShares Core MSCI Europe ETF10,459US$698K−233Jul 31, 2026
Dimensional International Core Equity Market ETF9,637US$642K−3,098Jul 31, 2026
International Small Cap Portfolio8,442US$469KNo changeJun 30, 2026
Dimensional International Core Equity 2 ETF7,912US$527KNo changeJul 31, 2026
WisdomTree International SmallCap Dividend Fund7,560US$419K+93Jun 30, 2026
Dimensional World ex. U.S. Core Equity 2 ETF5,442US$362KNo changeJul 31, 2026
Grandeur Peak Global Reach Fund5,257US$351KNo changeJul 31, 2026
Fidelity SAI International Small Cap Index Fund5,114US$341K+160Jul 31, 2026
State Street Global All Cap Equity ex-U.S. Index Portfolio4,698US$260KNo changeJun 30, 2026
Thrivent International Equity Portfolio4,192US$233KNo changeJun 30, 2026
iShares International Small-Cap Equity Factor ETF3,731US$249K−2,990Jul 31, 2026
AVIP Fidelity Institutional AM Equity Growth Portfolio3,662US$203KNo changeJun 30, 2026
Multi-Asset Strategy Fund3,659US$244KNewJul 31, 2026
Brighthouse/Dimensional International Small Company Portfolio3,635US$202KNo changeJun 30, 2026
WisdomTree Dynamic International Equity Fund3,072US$170K+2,834Jun 30, 2026
Vanguard ESG International Stock ETF2,971US$173KNo changeMay 31, 2026
WisdomTree Dynamic International SmallCap Equity Fund2,479US$137K−411Jun 30, 2026
Thrivent International Equity Fund2,459US$164KNo changeJul 31, 2026
Dimensional VA International Small Portfolio2,221US$148KNo changeJul 31, 2026
Guardian Large Cap Fundamental Growth VIP Fund2,149US$119KNo changeJun 30, 2026
Avantis International Small Cap Equity ETF2,070US$120K+315May 31, 2026

This page holds 50 of 67 holders. Open Shareholders

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Betina HagerupMember of the Board of Directors · Since at least Mar 2, 2026
Kristine FærchMember of the Board of Directors · Since at least Oct 9, 2025
Martin GlensbjergDeputy Chairman · Since at least Oct 9, 2025
Martin Helbo BehrensCEO · Since at least Sep 10, 2026
Niels ThestrupChairman of the Board · Since at least Oct 9, 2025
Peter ReichMember of the Board of Directors · Since at least Oct 9, 2025
Phillip Massie PriceCFO · Since at least Sep 10, 2026

Open People

Log in to ask 6ix AI your own questions about ChemoMetec A/S.